Navigation Links
Rigel Announces Third Quarter 2007 Financial Results
Date:11/6/2007

milestone and upfront payments from Merck Serono and Pfizer during the first nine months of 2006.

As of September 30, 2007, Rigel had cash, cash equivalents and available for sale securities of $112.5 million, compared with $126.5 million at June 30, 2007 and $104.5 million at December 31, 2006.

"Rigel's continued commitment to support a robust product pipeline has brought us to this point in the company's history where we expect to announce the results of two Phase 2 clinical trials with our lead drug candidate, R788, by the end of this year," said James M. Gower, Rigel's chairman and chief executive officer.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in seven strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

This press release contains "forward-looking" statements, including statements related to the timing of results of Rigel's clinical development of product candidates. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "plans," "intends," "indicates," "promising," "expects," "anticipates" and similar expressions are intended to identify these forward-looking sta
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 In ... (ADS) is offering advice for buying from a ... Dealers Association (NMEDA) is a nonprofit organization that ... in the manufacturing and installation of mobility equipment. ... in the industry that consistently adhere to the ...
(Date:3/31/2015)... FL (PRWEB) March 31, 2015 Medical ... America, has met all criteria for Laboratory Accreditation by ... given only to laboratories that apply rigid standards of ... performance of proficiency testing, and pass a rigorous on-site ... COLA accreditation as a result of a long-term commitment ...
(Date:3/31/2015)... The Walk a Mile Project, as part ... just kicked off their 3rd research sequence. The new ... Substantial Equivalence was and is a massive component of ... at Change The World Films. “We started our research ... even entered our food supply, just to get a bird's ...
(Date:3/31/2015)... 2015 At Summit Breast Care, their passion ... a calm and caring manner. , Summit Breast Care has ... treatment of breast cancer. They treat thousands of patients ... over the world. Their doctors continue to be recognized ... seeds for Summit Breast Care were planted in the mind ...
(Date:3/31/2015)... One of the most beautiful and awe-inspiring aspects of ... on the big island. The big island of Hawaii, after ... molten lava slowly oozing at your feet in one of the ... place you would never expect to see a live volcano spewing ... Texas -- until now. , Members of a local and independently ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Celebrates National Disability Month 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 2Health News:Rare Volcano Constructed inside Gold’s Gym in Mission, Texas 3
... researchers have found that children exposed to anesthesia during Cesarean ... later in life than children not delivered by C-section. These ... Anesthesiology . "We found that the ... delivered vaginally and those who were delivered via C-section but ...
... July 27 Grupo Casa Saba (NYSE: SAB ... leading Mexican,distributors of pharmaceutical products, health and beauty aids, personal ... consolidated financial and operating results for the second,quarter of 2009. ... (All figures are expressed in millions of Mexican ...
... , , , ... ULU ) ("the Company") today announced that it has collected $1,024,544 ... with the Promissory Note ("Note Agreement") between the Company and York Pharma, ... remittance, on July 22, 2009, the Company entered into a Forbearance Agreement ...
... St. Jude scientists identify new genes implicated in childhood ... detailed look at the complete AML genome , , ... yet of the genome of childhood acute myeloid leukemia (AML) found ... arises from just a handful of missteps, according to new findings ...
... CUPERTINO, Calif., July 27 In conjunction with DURECT ... press release, you are invited to listen to the conference call ... 3, 2009 at 4:30 pm Eastern Time (1:30 pm Pacific Time). ... , A live audio webcast of the presentation will ...
... , , , ... Inc. (NYSE: WPI ), a leader in generic and ... Vice President and Chief Financial Officer, has taken a leave of ... and Chief Executive Officer of Watson, announced that R. Todd Joyce, ...
Cached Medicine News:Health News:Mayo researchers find anesthesia not harmful for babies during birth process 2Health News:Mayo researchers find anesthesia not harmful for babies during birth process 3Health News:Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 2Health News:Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 3Health News:Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 4Health News:Grupo Casa Saba Announces Quarterly Earnings Report 2Q09 5Health News:ULURU Inc. Announces Status of York Note Receivable 2Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 2Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 3Health News:Comprehensive Look at Rare Leukemia Finds Relatively Few Genetic Changes Launch Disease 4Health News:DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 2Health News:Watson CFO Mark W. Durand to Take Leave of Absence 2
(Date:3/31/2015)... , March 31, 2015 UHC has released ... use of medical devices based on cost and quality ... preference items (PPIs). The study examined utilization of PPIs—which ... supply expenses 1 —at 10 academic medical centers, focusing ... and cardiac valves. The study, begun ...
(Date:3/31/2015)... Fla. , March 31, 2015 ... strategy and management consulting firm, has launched the ... to enable health IT vendors, payers and pharmacies ... the electronic prior authorization (ePA) of prescription medications. ... authorization (PA) requests are completed through time-consuming, manual ...
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
Breaking Medicine Technology:UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Point-of-Care Partners Launches the ePA State Navigator 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4
... Company (NYSE: CRDA ; CRDB) and leading third ... to announce that Gary Anderberg, Ph.D., practice leader for analytics ... & Insurance magazine,s 2010 Risk Innovators award. ... Broadspire,s e-Triage system, which helps analyze claims that might become ...
... Inc. (Nasdaq: SLTM ), a global leader in ... 69, Chief Technology Officer and a member of the company,s ... 1, 2010. Mr. DeBenedictis will be available to advise the ... to remain active in the development of other emerging medical ...
Cached Medicine Technology:Broadspire's Gary Anderberg Named Risk Innovator of the Year 2Broadspire's Gary Anderberg Named Risk Innovator of the Year 3Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc. 2
... ventilated microcentrifuge combines powerful, quiet performance with attractive, ... that gives you maximum value...MORE for LESS., ... to 17,000 xg at speeds of 13,500 rpm ... mL) microtubes., More Features , Microlite ...
... single rotation speed of 10,000 rpm , ... , Pellets single- and double-stranded DNA , ... , 12-position rotor holds 0.5-ml microcentrifuge tubes ... , Replaceable rotor , Safety ...
... The Centrifuge 4-15C is designed to accommodate ... provide the necessary force of more than 5600 ... wide range of both fixed-angle and swing-out rotors ... 5 ml, 15 ml, and 50 ml tubes, ...
... High performance Model 5417 C spins up to ... model offers unsurpassed safety, reliability, and ease of use. ... the lab bench or in a cold room and ... application range., Product features , Spin up ...
Medicine Products: